Does INFLIXIMAB-DYYB Cause Intentional dose omission? 393 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 393 reports of Intentional dose omission have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 1.5% of all adverse event reports for INFLIXIMAB-DYYB.
393
Reports of Intentional dose omission with INFLIXIMAB-DYYB
1.5%
of all INFLIXIMAB-DYYB reports
3
Deaths
119
Hospitalizations
How Dangerous Is Intentional dose omission From INFLIXIMAB-DYYB?
Of the 393 reports, 3 (0.8%) resulted in death, 119 (30.3%) required hospitalization, and 12 (3.1%) were considered life-threatening.
Is Intentional dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 393 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB-DYYB Cause?
Off label use (14,256)
Condition aggravated (10,275)
Intentional product use issue (7,549)
Inappropriate schedule of product administration (5,977)
Arthralgia (4,615)
Drug ineffective (3,112)
Fatigue (3,111)
Weight increased (2,848)
Malaise (2,766)
Weight decreased (2,703)
What Other Drugs Cause Intentional dose omission?
DUPILUMAB (2,269)
CERTOLIZUMAB PEGOL (1,253)
ADALIMUMAB (845)
TOFACITINIB (845)
INFLIXIMAB (815)
ABALOPARATIDE (623)
ETANERCEPT (615)
AMBRISENTAN (595)
SODIUM OXYBATE (580)
CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (518)
Which INFLIXIMAB-DYYB Alternatives Have Lower Intentional dose omission Risk?
INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX
INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT
INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE
INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B